For the Quarter Ending March 2026
Clindamycin Phosphate Prices in North America
- In United States, the Clindamycin Phosphate Price Index rose quarter-over-quarter in Q1 2026, driven by surging production costs.
- The Clindamycin Phosphate Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0%.
- The Clindamycin Phosphate Price Index climbed in March 2026 while the Consumer Price Index reached 3.3%.
- The Clindamycin Phosphate Demand Outlook strengthened in March 2026 because retail sales grew 4.0% year-over-year.
- Stable prescription volumes supported demand in March 2026 as the national unemployment rate stood at 4.3%.
- Discretionary dermatology demand faced headwinds in March 2026 when the consumer confidence index registered at 91.8.
- Constrained pharmaceutical manufacturing throughput occurred in March 2026 as industrial production recorded a 0.7% year-over-year increase.
- The Clindamycin Phosphate Price Forecast reflected upward pressure in March 2026 as the Manufacturing Index expanded.
Why did the price of Clindamycin Phosphate change in March 2026 in North America?
- Phosphate reagent costs surged in March 2026 due to tightened global supply and export restrictions.
- Natural gas energy costs surged in February and March 2026, increasing pharmaceutical manufacturing operational expenses.
- Corn fermentation feedstock inventories depleted at an accelerated pace during Q1 2026, driving prices upward.
Clindamycin Phosphate Prices in APAC
- In China, the Clindamycin Phosphate Price Index rose quarter-over-quarter in Q1 2026, driven by rising factory-gate prices.
- The Clindamycin Phosphate Production Cost Trend increased during February 2026 as imported excipient costs escalated due to tariffs.
- A 0.5% rise in the Producer Price Index during March 2026 reflected cost-push inflation for pharmaceutical manufacturing.
- The Clindamycin Phosphate Demand Outlook strengthened in February 2026, supported by increased hospital admissions for bacterial infections.
- Industrial production grew 5.7% and the Manufacturing Index expanded in March 2026, indicating robust pharmaceutical processing activity.
- A 1.0% Consumer Price Index increase in March 2026 indicated stable consumer purchasing power for healthcare products.
- Slower retail sales growth of 1.7% and a 5.4% unemployment rate in March 2026 limited discretionary spending.
- Consumer confidence at 91.6 in February 2026 indicated cautious spending, while the Clindamycin Phosphate Price Forecast remained stable.
Why did the price of Clindamycin Phosphate change in March 2026 in APAC?
- Imported active pharmaceutical ingredient and excipient costs escalated significantly due to tariffs in February 2026.
- Domestic healthcare infrastructure investments successfully bolstered product adoption and overall market demand in February 2026.
- Corn feedstock production costs stabilized as domestic agricultural yields expanded significantly in January 2026.
Clindamycin Phosphate Prices in Europe
- In Germany, the Clindamycin Phosphate Price Index rose quarter-over-quarter in Q1 2026, driven by surging natural gas costs.
- The Clindamycin Phosphate Production Cost Trend increased during March 2026 as CPI inflation reached 2.7 percent year-over-year.
- The Clindamycin Phosphate Demand Outlook strengthened in Q1 2026, supported by robust pharmaceutical antibiotic intermediate consumption.
- The Clindamycin Phosphate Price Forecast trended upward in Q1 2026 as energy feedstock inventories depleted rapidly under winter pressure.
- The Manufacturing Index expanded in March 2026, while industrial production remained flat at 0.0 percent year-over-year in February 2026.
- Retail sales contracted by 2.0 percent year-over-year in March 2026, reflecting weak consumer demand amid 6.3 percent unemployment.
- Consumer confidence dropped to negative 24.7 points in March 2026, while producer prices showed slight deflation at negative 0.2 percent.
- Non-EU import volumes of glucose feedstocks declined amid stricter trade documentation in Q1 2026, tightening regional supply.
Why did the price of Clindamycin Phosphate change in March 2026 in Europe?
- Natural gas energy costs surged in Germany during March 2026, elevating overall chemical manufacturing expenses.
- Pharmaceutical sector demand for phosphorus derivatives strengthened significantly in Q1 2026, driving market consumption.
- Middle East liquefied natural gas import volumes faced significant disruptions in Q1 2026, tightening supply.
For the Quarter Ending December 2025
Clindamycin Phosphate Prices in North America
- In the United States, the Clindamycin Phosphate Price Index rose quarter-over-quarter in Q4 2025, driven by elevated production costs.
- Clindamycin Phosphate production costs increased in Q4 2025, influenced by rising natural gas spot prices in the final months.
- A 3.0% year-over-year PPI increase in November 2025 indicated rising input costs for Clindamycin Phosphate manufacturers.
- The 2.7% year-over-year CPI increase in December 2025 contributed to higher operational costs for Clindamycin Phosphate production.
- Demand for topical Clindamycin Phosphate was supported by a 3.3% rise in retail sales in November 2025.
- US industrial production increased by 2.0% year-over-year in December 2025, supporting the broader supply chain.
- New tariffs on Chinese chemical imports in 2025 elevated procurement expenses for US chemical producers.
- US chemical product exports and imports both decreased in October 2025, reflecting reduced overall trade activity.
Why did the price of Clindamycin Phosphate change in December 2025 in North America?
- Rising natural gas spot prices in late 2025 increased Clindamycin Phosphate production costs.
- A 3.0% year-over-year PPI increase in November 2025 reflected higher input costs.
- New tariffs on Chinese chemical imports in 2025 elevated procurement expenses for the US industry.
Clindamycin Phosphate Prices in APAC
- In China, the Clindamycin Phosphate Price Index declined quarter-over-quarter in Q4 2025, influenced by weak consumer demand.
- Clindamycin Phosphate production costs faced downward pressure as producer prices declined by 1.9% in December 2025.
- Raw materials inventory contracted in October and December 2025, indicating tightening input availability for production.
- Clindamycin Phosphate demand was tempered by weak consumer spending, with retail sales growing 0.9% in December 2025.
- Robust pharmaceutical market growth in 2025, driven by an aging population, supported Clindamycin Phosphate demand.
- Industrial production grew by 5.2% in December 2025, supporting overall manufacturing activity for Clindamycin Phosphate.
- China's Manufacturing Index expanded in December 2025, indicating growth in the broader industrial environment.
- Clindamycin Phosphate price forecast suggests continued pressure from subdued consumer confidence in Q4 2025.
Why did the price of Clindamycin Phosphate change in December 2025 in China?
- Weak consumer demand, with 0.8% CPI in December 2025, reduced Clindamycin Phosphate demand.
- Producer prices declined by 1.9% in December 2025, lowering Clindamycin Phosphate production costs.
- Industrial production grew 5.2% in December 2025, supporting supply amidst raw material inventory contraction.
Clindamycin Phosphate Prices in Europe
- In Germany, the Clindamycin Phosphate Price Index fell in Q4 2025, influenced by producer price deflation.
- Production costs for Clindamycin Phosphate declined in December 2025, as the PPI fell by 2.5% year-over-year.
- Demand for Clindamycin Phosphate faced headwinds in December 2025 due to contracting manufacturing activity.
- Industrial production rose by 0.8% in October 2025, offering slight support for Clindamycin Phosphate demand.
- Consumer confidence declined to -17.5 in December 2025, impacting discretionary Clindamycin Phosphate product sales.
- Clindamycin Phosphate production costs increased in 2025 due to strengthened carbon pricing and higher EU electricity prices.
- Retail sales rose by 1.1% year-over-year in November 2025, supporting topical Clindamycin Phosphate demand.
- German exports remained robust in October 2025, indicating stable trade flows for pharmaceutical ingredients.
Why did the price of Clindamycin Phosphate change in December 2025 in Europe?
- Producer Price Index (PPI) declined by 2.5% year-over-year in December 2025, reducing Clindamycin Phosphate production costs.
- Contracting manufacturing activity in December 2025 signaled weaker demand for Clindamycin Phosphate from pharmaceutical manufacturers.
- Strengthened carbon pricing and increased electricity costs in 2025 pressured Clindamycin Phosphate production expenses.
For the Quarter Ending September 2025
Clindamycin Phosphate Prices in North America
- In United States, the Clindamycin Phosphate Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs and strong pharmaceutical market sentiment.
- Overall input and raw material costs for chemical manufacturers strengthened in Q3 2025, alongside rising energy expenses.
- The Consumer Price Index increased 3.0% in September 2025, and the Producer Price Index rose 2.6% in August 2025.
- US pharmaceutical market sentiment strengthened in Q3 2025, with national health spending growth accelerating.
- US chemical production levels contracted in Q3 2025, and industry inventories shrank due to accelerating destocking.
- US pharmaceutical product exports strengthened from July to August 2025, while imports weakened.
- Henry Hub natural gas spot prices showed an upward trend towards Q3 2025 end, impacting energy feedstock costs.
- Retail sales grew 5.42% in September 2025, supporting demand, despite consumer confidence declining to 94.2.
Why did the price of Clindamycin Phosphate change in September 2025 in North America?
- Production costs rose due to a 3.0% CPI increase in September 2025 and strengthened raw material expenses.
- Supply tightened as US chemical production contracted in Q3 2025, with industrial production growing only 0.1%.
- Demand was supported by strengthened US pharmaceutical market sentiment and 5.42% retail sales growth in September 2025.
APAC
- In China, the Clindamycin Phosphate Price Index fell quarter-over-quarter in Q3 2025, influenced by a -2.3% PPI year-on-year in September.
- Clindamycin Phosphate production costs faced mixed pressures in Q3 2025, with general input costs rising but industrial electricity rates reduced.
- Clindamycin Phosphate demand was supported by a 6.5% industrial production increase and 3.0% retail sales growth in September.
- Cautious consumer confidence at 89.6 in September 2025 and a -0.3% CPI year-on-year impacted discretionary demand.
- Raw material inventories for manufacturing declined in July 2025, with the rate of decline narrowing by September.
- China's manufacturing sector saw new export orders rise in September 2025, reflecting improved international trade flows.
- Natural gas prices remained stable throughout Q3 2025, providing consistent energy feedstock costs for Clindamycin Phosphate.
- Pharmaceutical market demand increased in Q3 2025, driven by an aging population and rising prevalence of chronic diseases.
Why did the price of Clindamycin Phosphate change in September 2025 in APAC?
- A -2.3% PPI year-on-year in September 2025 reduced factory-gate prices, impacting Clindamycin Phosphate prices.
- Cautious consumer confidence at 89.6 in September 2025 impacted discretionary spending for pharmaceutical products.
- Rising general manufacturing input costs in Q3 2025 exerted upward pressure on Clindamycin Phosphate production expenses.
Europe
- In Germany, the Clindamycin Phosphate Price Index rose quarter-over-quarter in Q3 2025, driven by elevated costs and supply disruptions.
- Clindamycin Phosphate production costs remained high in Q3 2025, influenced by elevated raw material costs and 2.4% CPI in September 2025.
- Despite -1.7% PPI in September 2025, industrial electricity costs remained elevated throughout Q3 2025.
- Clindamycin Phosphate demand was mixed in Q3 2025, with moderate pharmaceutical growth and negative consumer confidence (-23.6, September 2025).
- Industrial production in Germany declined 1.0% year-over-year in September 2025, impacting supply chains.
- Regional supply tightened in Q3 2025 due to unexpected plant disruptions, including a July 2025 fire.
- German chemical sales outside Europe weakened in Q3 2025, while European sales stagnated.
- The Manufacturing Index trend was contracting in September 2025, signaling industrial activity slowdown.
- Natural gas prices fluctuated in Q3 2025, slightly increasing in September compared to August.
Why did the price of Clindamycin Phosphate change in September 2025 in Europe?
- Elevated raw material costs and 2.4% CPI in September 2025 increased production expenses.
- Regional supply tightened in Q3 2025 due to plant disruptions, limiting Clindamycin Phosphate availability.
- Contracting industrial production (-1.0%, September 2025) and negative consumer confidence (-23.6, September 2025) tempered demand.
For the Quarter Ending December 2022
North America
North American region, particularly the USA, witnessed an inclined price trend for Clindamycin Phosphate during the start of October. Increased end-user demand balanced with enough supplies among the market participants kept the prices of Clindamycin Phosphate on the higher side.
Slowing economic activity amid rising borrowing costs, Consumer spending, which edged up 0.1% after surging 0.9% in October, and ease in trade disruption along with shipment cost supported the market sentiments of Clindamycin Phosphate in the USA.
Until November, the cost of Clindamycin Phosphate got settled at USD 146520/MT CFR Los Angeles in the USA. Towards the end of the fourth quarter of 2022, the prices fell significantly, backed by decremented inquiries coupled with the temporary shutdown of the domestic market owing to New-year holidays.
APAC
The prices of Clindamycin Phosphate plummeted at the end of 2022 in the Asia Pacific region, primarily in China. At the start of the fourth quarter, the market of Clindamycin Phosphate visualized a positive market outlook as the demand inclined considerably following the trend of the previous month. Following November, the ease in supply disruption and port congestion at the importing countries additionally supported the price trends of Clindamycin Phosphate and got settled at USD 145255/MT FOB Shanghai. With the start of December, demand in China remains largely dormant, as an outburst of lockdowns of COVID-19 has muted economic output and affected the market sentiments of all the commodities, including Clindamycin Phosphate in China.
Europe
During the fourth quarter of 2022, the European market for Clindamycin Phosphate imitated a similar pattern as that of APAC. The market initially started on a healthy note up to November as the demand from the end-user sector of the pharmaceutical industry increased, which was balanced with the overall supplies among the market participants. After November, the witnesses for the Clindamycin Phosphate pricing were gathered at USD 150640/MT CFR Hamburg. Additionally, in November, the downstream industry started to moderately raise its requests for rates on Clindamycin Phosphate, which helped to keep prices on the higher side. Fresher orders decreased in December of 2022 due to suppliers having high stock levels due to the market's brief closure.
